Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

NCT02243579

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +19 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Yale University New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

NCT01305200

Conditions
Bone Marrow Diseases, Burkitt Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, +89 more
Locations
  • Children's Oncology Group Arcadia, California, United States
  • City of Hope Duarte, California, United States
  • Children's Hospital and Research Center at Oakland Oakland, California, United States
  • Rady Children's Hospital - San Diego San Diego, California, United States
View all 35 locations
View Trial Details
Completed

Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00044954

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +41 more
Locations
  • Rocky Mountain Cancer Centers - Denver Midtown Denver, Colorado, United States
  • Florida Hospital Cancer Institute Orlando, Florida, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States
View all 14 locations
View Trial Details
Completed

A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

NCT00875667

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • UZ Brussels Brussels, Belgium
  • UZ Gent Ghent, Belgium
  • AZ Groeninge Kortrijk, Belgium
  • Cliniques Universitaires UCL de Mont-Godine Yvoir, Belgium
View all 97 locations
View Trial Details
Completed

Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma

NCT00169208

Conditions
Disease Attributes, Follicular Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations
  • Service de médecine D - Maladies du Sang CHU Angers Angers, France
  • Service d'Hématologie Hôpital Jean Minjoz Besançon, France
  • Hôpital Henri Mondor Créteil, France
  • Hôpital A. Michallon BP 217X Grenoble, France
View all 16 locations
View Trial Details
Completed

S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

NCT00770224

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Saint Anthony's Hospital at Saint Anthony's Health Center Alton, Illinois, United States
  • Cancer Care Center of Decatur Decatur, Illinois, United States
View all 114 locations
View Trial Details
Completed

R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

NCT00137995

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Australian leukemia and lymphoma group Sydney, Australia
  • Groupe d'atude des lymphome de l'adulte Yvoir, Belgium
  • Czech Lymphoma study group Prague, Czechia
View Trial Details

Related conditions